Uncategorized
FDA Awards Grant for Phase 2 Trial to Deliver Sustainable LCA Treatment
Applied Genetic Technologies Corporation
(Gainesville, FL) announced that it has received a
$1 million grant from the FDA through its Orphan Drugs
Program to fund a phase 2 human clinical trial evaluating
the safety and efficacy of a treatment for Leber congenital
amaurosis, according to a company news release.
The tr...